Name: Cabozantinib 60mg Tablets for Kidney Thyroid Liver Cancer Treatment
Brand: GIVE LIFE TIME LIMITED
SKU: XL-184
Price: 55342706 USD
Availability: InStock

Detail Information

Specifications::	60mg*30 Tablets/bottle/box	Indications:	Kidney Cancer, Thyroid Cancer, Liver Cancer, Soft Tissue Sarcoma, Non-small Cell Lung Cancer, Prostate Cancer, Breast Cancer, Ovarian Cancer, Bowel Cancer
Target:	RET、MET、VEGFR-1,2,3、KIT	Product Name:	Cabozantinib
Recommended Dose:	Please Follow Doctor's Advice	Storage:	Store Cabozantinib At 20°C To 25°C (68°F To 77°F); Excursions Allowed From 15°C To 30°C (59°F To 86°F).
Highlight:	skin endocrine rheumatism drugs wholesaler , wholesaler skin endocrine rheumatism drugs , wholesaler skin endocrine rheumatism drug

Product Description

Cabozantinib XL-184 (Cabozanix) 60mg Tablets

Product Specifications

Attribute	Value
Specifications	60mg*30 tablets/bottle/box
Indications	Kidney cancer, thyroid cancer, liver cancer, soft tissue sarcoma, non-small cell lung cancer, prostate cancer, breast cancer, ovarian cancer, bowel cancer
Target	RET, MET, VEGFR-1,2,3, KIT
Recommended Dose	Please follow doctor's advice
Storage	Store at 20°C to 25°C (68°F to 77°F); excursions allowed from 15°C to 30°C (59°F to 86°F)

Description

Generic name: cabozantinib

Other names: cabozantinib/XL184

Indications

Treatment of progressive, unresectable locally advanced or metastatic medullary thyroid cancer and advanced kidney cancer that has failed Sutent.

Dosage and Administration

Recommended dosage: 60 mg daily. Do not take with food. Avoid eating for at least 2 hours before and 1 hour after taking.

Swallow tablets whole; do not crush. Continue treatment until clinical benefit ceases or unacceptable toxicity occurs.

Dosage Adjustments

Discontinue 28 days before scheduled surgery
For Grade 4 adverse reactions or intolerable Grade 2-3 reactions, withhold and reduce dose
Permanently discontinue for severe bleeding, arterial thromboembolic events, or uncontrolled hypertension

Warnings and Precautions

Bleeding: Serious bleeding occurred in 2.1% of patients. Do not use in patients with severe bleeding risk.

GI Perforation/Fistula: Reported in 0.9-1.2% of patients. Monitor closely and discontinue if occurs.

Thrombotic Events: Increased incidence of venous (7.3%) and arterial (0.9%) thromboembolism.

Hypertension: Occurred in 37% of patients (15% ≥ grade 3). Monitor blood pressure regularly.

Diarrhea: Occurred in 74% of patients (11% grade 3). Manage with antidiarrheals and dose reduction.

Adverse Reactions

Most common (≥25%): diarrhea, fatigue, nausea, anorexia, palmoplantar erythrodysesthesia syndrome (PPES), hypertension, vomiting, weight loss, constipation.

Special Populations

Pregnancy: May cause fetal harm. Use effective contraception during and for 4 months after treatment
Breastfeeding: Avoid during treatment and for 4 months after final dose
Hepatic Impairment: Reduce dose for mild-moderate impairment. Avoid in severe impairment
Elderly: No significant differences in safety/efficacy observed

Additional Information

Cabozantinib Mechanism of Action

Cabozantinib Side Effects

Cabozantinib Package Insert

Tag:

Place of Origin:	Bangladesh
Brand Name:	Cabozanix
Model Number:	XL-184

Minimum Order Quantity:	1 PCS
Price:	Please contact a specialist WhatsApp：55342706
Packaging Details:	Negotiable
Delivery Time:	Negotiable
Payment Terms:	Western Union,MoneyGram,T/T
Supply Ability:	Negotiable

Cabozantinib 60mg Tablets for Kidney Thyroid Liver Cancer Treatment

skin endocrine rheumatism drugs wholesaler

wholesaler skin endocrine rheumatism drugs

wholesaler skin endocrine rheumatism drug

cancer treatment drugs,

lung cancer medication,

non small cell lung cancer drugs

New Lung Cancer Drug Trametinib Mekinist 2mg Lung Cancer Pill

90 Capsules Entrectinib Rozlytrek 200mg Drugs To Treat Lung Cancer

100mg Nintedanib Nydeni Immunotherapy Drugs For Lung Cancer

Entrectinib 100mg*60 Capsules for NTRK Fusion Solid Tumors

Nintedanib 150mg Soft Capsules for Lung Cancer & Pulmonary Fibrosis

Dabrafenib 50mg Capsules for BRAF V600+ Melanoma & NSCLC

Novartis、Phokam Mekinist GSK1120212 Trametinb 2mg*30 tablets Non-small cell lung cancer, colorectal cancer, thyroid cancer, melanomafor stage 1 2 3 cancer

NOVARTIS Trametinb GSK1120212 Mekinist 2mg*30 tablets for stage 1 2 3 lung cancer Non-small cell lung cancer, colorectal cancer, thyroid cancer, melanoma